Medical Developments International Limited
Simbol: MVP.AX
ASX
0.59
AUDTržna cena danes
-2.0215
Razmerje P/E
0.1080
Razmerje PEG
50.92M
Kapaciteta MRK
- 0.00%
Donos DIV
Medical Developments International Limited (MVP-AX) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 97.88 | 24.7 | 20.4 | 36.3 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 26.01 | 8.9 | 6.2 | 5 | |||||||||||||||||||||
balance-sheet.row.inventory | 35.57 | 8.4 | 7.1 | 5.7 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 3.35 | 0.8 | 0.6 | 0.4 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 162.8 | 42.8 | 34.4 | 47.4 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 46.89 | 12.1 | 11.6 | 11.7 | |||||||||||||||||||||
balance-sheet.row.goodwill | 7.62 | 3.8 | 3.8 | 4.4 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 92.91 | 8.5 | 8 | 8.2 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 100.53 | 12.3 | 11.8 | 12.6 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 32.04 | -3.8 | -3.8 | -4.4 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 45.75 | 16.3 | 14.8 | 2.2 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 22.91 | 29.9 | 32.7 | 30.6 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 248.12 | 66.7 | 67 | 52.8 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 410.92 | 109.5 | 101.4 | 100.2 | |||||||||||||||||||||
balance-sheet.row.account-payables | 47.97 | 13.3 | 9.4 | 3.3 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 1.41 | 0.4 | 0.3 | 0.3 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 9.08 | 2.2 | 2.5 | 2.7 | |||||||||||||||||||||
Deferred Revenue Non Current | 27.5 | 1.9 | 21.6 | 21.9 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 17.31 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 2.73 | 1.6 | 0.7 | 3.3 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 55.4 | 12.6 | 33.6 | 24.9 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 9.08 | 2.2 | 2.5 | 2.7 | |||||||||||||||||||||
balance-sheet.row.total-liab | 108.23 | 28.2 | 44.1 | 31.9 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 393.8 | 105.7 | 77 | 76.9 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | -109.4 | -30.2 | -24.5 | -12.1 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 18.28 | 5.7 | 4.9 | 3.5 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 302.68 | 81.3 | 57.3 | 68.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 410.92 | 109.5 | 101.4 | 100.2 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | 302.68 | 81.3 | 57.3 | 68.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 410.92 | - | - | - | |||||||||||||||||||||
Total Investments | 32.04 | -3.8 | -3.8 | -4.4 | |||||||||||||||||||||
balance-sheet.row.total-debt | 10.49 | 2.6 | 2.8 | 3 | |||||||||||||||||||||
balance-sheet.row.net-debt | -87.39 | -22.1 | -17.6 | -33.2 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -21.58 | -5.6 | -12.4 | -12.6 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6.14 | 3.1 | 2.9 | 3.7 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | -16.12 | -7.4 | -8.4 | -0.1 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 7.08 | 1.3 | 1 | 1.2 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | -9.12 | -2.5 | -3.6 | -9.9 | ||||||||||||||||||||
cash-flows.row.account-receivables | -1.4 | -2.9 | -2.5 | 1.4 | ||||||||||||||||||||
cash-flows.row.inventory | -3.45 | -1.8 | -1.4 | 0.2 | ||||||||||||||||||||
cash-flows.row.account-payables | 0.48 | 4.8 | 2.3 | 1 | ||||||||||||||||||||
cash-flows.row.other-working-capital | -2.87 | -2.6 | -2.1 | -12.5 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 4.83 | -5.4 | 9.8 | 8.9 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -28.71 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -11.45 | -7.7 | -5.2 | -6.6 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | -7.54 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -11.45 | -7.7 | -5.2 | -6.6 | ||||||||||||||||||||
cash-flows.row.debt-repayment | -0.26 | -0.3 | -0.2 | -0.1 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 28.57 | 28.3 | 0.4 | 36.3 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.53 | -1.7 | 0 | -0.7 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -26.4 | -0.1 | -35.5 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 27.79 | 28.1 | 0.1 | 36.1 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 27.54 | 28.1 | 0.1 | 36.1 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.05 | 0.4 | -0.1 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | -12.58 | 4.3 | -15.9 | 20.7 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 97.88 | 24.7 | 20.4 | 36.3 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 110.45 | 20.4 | 36.3 | 15.5 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | -28.71 | -16.5 | -10.7 | -8.8 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | -11.45 | -7.7 | -5.2 | -6.6 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | -40.16 | -24.2 | -15.9 | -15.4 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 60.19 | 32.3 | 21.9 | 25.3 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 58.93 | 34.9 | 25 | 8.6 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 1.26 | -2.5 | -3.1 | 16.7 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 0.34 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 34.33 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 6.63 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 19.1 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 40.96 | 17.8 | 12.6 | 21.9 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 99.89 | 52.6 | 37.6 | 30.5 | |||||||||||||||||||||
income-statement-row.row.interest-income | 0.93 | 0.7 | 0.5 | 0.1 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0.19 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 6.63 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 12.96 | 12.8 | -0.2 | -9.7 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 19.1 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 12.96 | 12.8 | -0.2 | -9.7 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0.19 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 6.14 | 3.1 | 2.9 | 3.7 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | -33.56 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | -39.7 | -20.3 | -15.7 | -5.2 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | -26.73 | -7.5 | -15.9 | -15 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | -5.15 | -1.9 | -3.5 | -2.4 | |||||||||||||||||||||
income-statement-row.row.net-income | -21.58 | -5.6 | -12.4 | -12.6 |
Pogosto zastavljeno vprašanje
Kaj je Medical Developments International Limited (MVP.AX) skupna sredstva?
Medical Developments International Limited (MVP.AX) skupna sredstva so 109486000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 33494000.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je -0.215.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je -0.239.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je -0.574.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so -0.750.
Kaj je Medical Developments International Limited (MVP.AX) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -5609000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 2560000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 17757000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 15699000.000.